Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The worldwide Anthrax Vaccines market was valued at 510 Million US$ in 2018 and is projected to reach 916 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 7.6% during the forecast period.
This report presents the market size and development trends by detailing the Anthrax Vaccines market revenue, market share and growth rate from 2015-2026, and it gives a thorough analysis by various product types, applications, regions, and main participants. The market conditions (2015-2019), corporate competition pattern, corporate SWOT analysis are elaborated, and other qualitative analyses like market dynamics, market penetration, market business environment analyses, the regional regulatory scenario in the Anthrax Vaccines market will be shown in this report. In short, this report will comprehensively reveal the characteristics of Anthrax Vaccines industry and will help you to build a panoramic view of the industrial development.
Anthrax Vaccines Market, By Type:
Cell free PA Vaccines
Live Vaccines
Anthrax Vaccines Market, By Application:
Human
Animals
Some of the leading players are as follows:
Centro Diagnóstico Veterinario
KAKETSUKEN (Chemo-Sero-Therapeutic Research Institute)
Institute for Biological Products
Empresa Colombiana de Productos Veterinarios S.A. (PharmAthene)
Central Veterinary Control and Research Institute
CDV Limited
Colorado Serum
Jordan Bio-Industries Center (CVCRI)
Intervac
Instituto JOVAC S.A.
Biogénesis-Bago Argentina
IVPM (PVT) Ltd.
Merck
Laboratorios Laverlam S.A.
Bayer Sanidad Animal Company
Zoetis
Laboratorio Merial S.A.
Rosenbusch S.A.
Institute of Animal Health and Veterinary Biologicals
Indian Immunologicals
Institutul Pasteur
Institute of Veterinary Preventive Medicine
Geographically, Major regions are analyzed in details are as follows:
-
North America
-
Europe
-
Asia Pacific
-
Latin America
-
Middle East & Africa
Table of Contents
1 Methodology and Scope
-
1.1 Market Segmentation & Scope
-
1.1.1 Technology Type
-
1.1.2 Product
-
1.1.3 Application
-
1.1.4 Regional scope
-
1.1.5 Estimates and forecast timeline
-
1.2 Research Methodology
-
1.3 Information Procurement
-
1.3.1 Purchased database
-
1.3.2 Internal database
-
1.3.3 Secondary sources
-
1.3.4 Primary research
-
1.3.5 Details of primary research
-
1.4 Information or Data Analysis
-
1.4.1 Data analysis models
-
1.5 Market Formulation & Validation
-
1.6 Model Details
-
1.6.1 Commodity flow analysis
-
1.6.2 Volume price analysis
-
1.7 List of Secondary Sources
-
1.8 List of Abbreviations
2 Executive Summary
-
2.1 Market Outlook
-
2.2 Segment Outlook
3 Market Variables, Trends, & Scope
-
3.1 Market Lineage Outlook
-
3.1.1 Parent market outlook
-
3.1.2 Ancillary market outlook
-
3.2 Market Segmentation
-
3.2.1 Analysis
-
3.3 Market Dynamics
-
3.3.1 Market driver analysis
-
3.3.2 Market restraint analysis
-
3.3.3 Industry opportunities
-
3.4 Penetration & Growth Prospect Mapping
-
3.4.1 Penetration & growth prospect mapping analysis
-
3.5 Business Environment Analysis Tools
-
3.5.1 Porter's five forces analysis
-
3.5.2 PESTLE analysis
-
3.5.3 Major deals & strategic alliances analysis
4 Anthrax Vaccines Market: Technology Type Analysis
-
4.1 Anthrax Vaccines Technology Type Market Share Analysis, 2018 & 2026
-
4.2 Anthrax Vaccines Technology Type Market: Segment Dashboard
-
4.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Technology Type Segment
4.3.1 Cell free PA Vaccines
4.3.2 Live Vaccines
5 Anthrax Vaccines Market: Product Analysis
-
5.1 Anthrax Vaccines Product Market Share Analysis, 2018 & 2026
-
5.2 Anthrax Vaccines Product Market: Segment Dashboard
-
5.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Product Segment
6 Anthrax Vaccines Market: Application Analysis
-
6.1 Anthrax Vaccines Application Market Share Analysis, 2018 & 2026
-
6.2 Anthrax Vaccines Application Market: Segment Dashboard
-
6.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Application Segment
6.3.1 Human
6.3.2 Animals
7 Anthrax Vaccines Market: Regional Analysis
-
7.1 Anthrax Vaccines Regional Market Share Analysis, 2018 & 2026
-
7.2 Anthrax Vaccines Regional Market: Segment Dashboard
-
7.3 Regional Market Snapshot (Market Size, CAGR, Top Countries)
-
7.4 List of Players at Regional Level
-
7.4.1 North America
-
7.4.2 Europe
-
7.4.3 Asia Pacific
-
7.5 SWOT Analysis, by Factor (Political & Legal, Economic and Technological)
-
7.5.1 North America
-
7.5.2 Europe
-
7.5.3 Asia Pacific
-
7.5.4 Latin America
-
7.5.5 MEA
-
7.6 Market Size & Forecasts, and Trend Analysis, 2015 to 2026
-
7.6.1 North America
-
7.6.2 Europe
-
7.6.3 Asia Pacific
-
7.6.4 Latin America
-
7.6.5 Middle East & Africa
8 Competitive Analysis
-
8.1 Recent Developments & Impact Analysis, by Key Market Participants
-
8.2 Strategic Framework/Competition Categorization (Key innovators, Market leaders, Emerging players)
-
8.3 Vendor Landscape
-
8.3.1 Company market position analysis (Geographic presence, service portfolio, strategic initiatives)
9 Company Profiles
9.1 Centro Diagnóstico Veterinario
9.1.1 Centro Diagnóstico Veterinario Company overview
9.1.2 Financial performance
9.1.3 Product benchmarking
9.1.4 Strategic initiatives
9.1.5 SWOT analysis
9.2 KAKETSUKEN (Chemo-Sero-Therapeutic Research Institute)
9.2.1 KAKETSUKEN (Chemo-Sero-Therapeutic Research Institute) Company overview
9.2.2 Financial performance
9.2.3 Product benchmarking
9.2.4 Strategic initiatives
9.2.5 SWOT analysis
9.3 Institute for Biological Products
9.3.1 Institute for Biological Products Company overview
9.3.2 Financial performance
9.3.3 Product benchmarking
9.3.4 Strategic initiatives
9.3.5 SWOT analysis
9.4 Empresa Colombiana de Productos Veterinarios S.A. (PharmAthene)
9.4.1 Empresa Colombiana de Productos Veterinarios S.A. (PharmAthene) Company overview
9.4.2 Financial performance
9.4.3 Product benchmarking
9.4.4 Strategic initiatives
9.4.5 SWOT analysis
9.5 Central Veterinary Control and Research Institute
9.5.1 Central Veterinary Control and Research Institute Company overview
9.5.2 Financial performance
9.5.3 Product benchmarking
9.5.4 Strategic initiatives
9.5.5 SWOT analysis
9.6 CDV Limited
9.6.1 CDV Limited Company overview
9.6.2 Financial performance
9.6.3 Product benchmarking
9.6.4 Strategic initiatives
9.6.5 SWOT analysis
9.7 Colorado Serum
9.7.1 Colorado Serum Company overview
9.7.2 Financial performance
9.7.3 Product benchmarking
9.7.4 Strategic initiatives
9.7.5 SWOT analysis
9.8 Jordan Bio-Industries Center (CVCRI)
9.8.1 Jordan Bio-Industries Center (CVCRI) Company overview
9.8.2 Financial performance
9.8.3 Product benchmarking
9.8.4 Strategic initiatives
9.8.5 SWOT analysis
9.9 Intervac
9.9.1 Intervac Company overview
9.9.2 Financial performance
9.9.3 Product benchmarking
9.9.4 Strategic initiatives
9.9.5 SWOT analysis
9.10 Instituto JOVAC S.A.
9.10.1 Instituto JOVAC S.A. Company overview
9.10.2 Financial performance
9.10.3 Product benchmarking
9.10.4 Strategic initiatives
9.10.5 SWOT analysis
9.11 Biogénesis-Bago Argentina
9.11.1 Biogénesis-Bago Argentina Company overview
9.11.2 Financial performance
9.11.3 Product benchmarking
9.11.4 Strategic initiatives
9.11.5 SWOT analysis
9.12 IVPM (PVT) Ltd.
9.12.1 IVPM (PVT) Ltd. Company overview
9.12.2 Financial performance
9.12.3 Product benchmarking
9.12.4 Strategic initiatives
9.12.5 SWOT analysis
9.13 Merck
9.13.1 Merck Company overview
9.13.2 Financial performance
9.13.3 Product benchmarking
9.13.4 Strategic initiatives
9.13.5 SWOT analysis
9.14 Laboratorios Laverlam S.A.
9.14.1 Laboratorios Laverlam S.A. Company overview
9.14.2 Financial performance
9.14.3 Product benchmarking
9.14.4 Strategic initiatives
9.14.5 SWOT analysis
9.15 Bayer Sanidad Animal Company
9.15.1 Bayer Sanidad Animal Company Company overview
9.15.2 Financial performance
9.15.3 Product benchmarking
9.15.4 Strategic initiatives
9.15.5 SWOT analysis
9.16 Zoetis
9.16.1 Zoetis Company overview
9.16.2 Financial performance
9.16.3 Product benchmarking
9.16.4 Strategic initiatives
9.16.5 SWOT analysis
9.17 Laboratorio Merial S.A.
9.17.1 Laboratorio Merial S.A. Company overview
9.17.2 Financial performance
9.17.3 Product benchmarking
9.17.4 Strategic initiatives
9.17.5 SWOT analysis
9.18 Rosenbusch S.A.
9.18.1 Rosenbusch S.A. Company overview
9.18.2 Financial performance
9.18.3 Product benchmarking
9.18.4 Strategic initiatives
9.18.5 SWOT analysis
9.19 Institute of Animal Health and Veterinary Biologicals
9.19.1 Institute of Animal Health and Veterinary Biologicals Company overview
9.19.2 Financial performance
9.19.3 Product benchmarking
9.19.4 Strategic initiatives
9.19.5 SWOT analysis
9.20 Indian Immunologicals
9.20.1 Indian Immunologicals Company overview
9.20.2 Financial performance
9.20.3 Product benchmarking
9.20.4 Strategic initiatives
9.20.5 SWOT analysis
9.21 Institutul Pasteur
9.21.1 Institutul Pasteur Company overview
9.21.2 Financial performance
9.21.3 Product benchmarking
9.21.4 Strategic initiatives
9.21.5 SWOT analysis
9.22 Institute of Veterinary Preventive Medicine
9.22.1 Institute of Veterinary Preventive Medicine Company overview
9.22.2 Financial performance
9.22.3 Product benchmarking
9.22.4 Strategic initiatives
9.22.5 SWOT analysis
The List of Tables and Figures (Totals 65 Figures and 139 Tables)
Figure Cell free PA Vaccines Anthrax Vaccines market, 2015 - 2026 (USD Million)
Figure Live Vaccines Anthrax Vaccines market, 2015 - 2026 (USD Million)
Figure Human market, 2015 - 2026 (USD Million)
Figure Animals market, 2015 - 2026 (USD Million)
-
Table List of players in North America
-
Table List of players in Europe
-
Table List of players in Asia Pacific
-
Table SWOT analysis
-
Table North America Anthrax Vaccines market, by country, 2015 - 2026 (USD Million)
-
Table North America Anthrax Vaccines market, by type, 2015 - 2026 (USD Million)
-
Table North America Anthrax Vaccines market, by product, 2015 - 2026 (USD Million)
-
Table North America Anthrax Vaccines market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table U.S. Anthrax Vaccines market, by type, 2015 - 2026 (USD Million)
-
Table U.S. Anthrax Vaccines market, by product, 2015 - 2026 (USD Million)
-
Table U.S. Anthrax Vaccines market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Canada Anthrax Vaccines market, by type, 2015 - 2026 (USD Million)
-
Table Canada Anthrax Vaccines market, by product, 2015 - 2026 (USD Million)
-
Table Canada Anthrax Vaccines market, by application, 2015 - 2026 (USD Million)
-
Table Europe Anthrax Vaccines market, by country, 2015 - 2026 (USD Million)
-
Table Europe Anthrax Vaccines market, by type, 2015 - 2026 (USD Million)
-
Table Europe Anthrax Vaccines market, by product, 2015 - 2026 (USD Million)
-
Table Europe Anthrax Vaccines market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table U.K. Anthrax Vaccines market, by type, 2015 - 2026 (USD Million)
-
Table U.K. Anthrax Vaccines market, by product, 2015 - 2026 (USD Million)
-
Table U.K. Anthrax Vaccines market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Germany Anthrax Vaccines market, by type, 2015 - 2026 (USD Million)
-
Table Germany Anthrax Vaccines market, by product, 2015 - 2026 (USD Million)
-
Table Germany Anthrax Vaccines market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table France Anthrax Vaccines market, by type, 2015 - 2026 (USD Million)
-
Table France Anthrax Vaccines market, by product, 2015 - 2026 (USD Million)
-
Table France Anthrax Vaccines market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Italy Anthrax Vaccines market, by type, 2015 - 2026 (USD Million)
-
Table Italy Anthrax Vaccines market, by product, 2015 - 2026 (USD Million)
-
Table Italy Anthrax Vaccines market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Spain Anthrax Vaccines market, by type, 2015 - 2026 (USD Million)
-
Table Spain Anthrax Vaccines market, by product, 2015 - 2026 (USD Million)
-
Table Spain Anthrax Vaccines market, by application, 2015 - 2026 (USD Million)
-
Table Asia Pacific Anthrax Vaccines market, by country, 2015 - 2026 (USD Million)
-
Table Asia Pacific Anthrax Vaccines market, by type, 2015 - 2026 (USD Million)
-
Table Asia Pacific Anthrax Vaccines market, by product, 2015 - 2026 (USD Million)
-
Table Asia Pacific Anthrax Vaccines market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table China Anthrax Vaccines market, by type, 2015 - 2026 (USD Million)
-
Table China Anthrax Vaccines market, by product, 2015 - 2026 (USD Million)
-
Table China Anthrax Vaccines market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Japan Anthrax Vaccines market, by type, 2015 - 2026 (USD Million)
-
Table Japan Anthrax Vaccines market, by product, 2015 - 2026 (USD Million)
-
Table Japan Anthrax Vaccines market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table India Anthrax Vaccines market, by type, 2015 - 2026 (USD Million)
-
Table India Anthrax Vaccines market, by product, 2015 - 2026 (USD Million)
-
Table India Anthrax Vaccines market, by application, 2015 - 2026 (USD Million)
-
Table Latin America Anthrax Vaccines market, by country, 2015 - 2026 (USD Million)
-
Table Latin America Anthrax Vaccines market, by type, 2015 - 2026 (USD Million)
-
Table Latin America Anthrax Vaccines market, by product, 2015 - 2026 (USD Million)
-
Table Latin America Anthrax Vaccines market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Brazil Anthrax Vaccines market, by type, 2015 - 2026 (USD Million)
-
Table Brazil Anthrax Vaccines market, by product, 2015 - 2026 (USD Million)
-
Table Brazil Anthrax Vaccines market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Mexico Anthrax Vaccines market, by type, 2015 - 2026 (USD Million)
-
Table Mexico Anthrax Vaccines market, by product, 2015 - 2026 (USD Million)
-
Table Mexico Anthrax Vaccines market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Argentina Anthrax Vaccines market, by type, 2015 - 2026 (USD Million)
-
Table Argentina Anthrax Vaccines market, by product, 2015 - 2026 (USD Million)
-
Table Argentina Anthrax Vaccines market, by application, 2015 - 2026 (USD Million)
-
Table MEA Anthrax Vaccines market, by country, 2015 - 2026 (USD Million)
-
Table MEA Anthrax Vaccines market, by type, 2015 - 2026 (USD Million)
-
Table MEA Anthrax Vaccines market, by product, 2015 - 2026 (USD Million)
-
Table MEA Anthrax Vaccines market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table South Africa Anthrax Vaccines market, by type, 2015 - 2026 (USD Million)
-
Table South Africa Anthrax Vaccines market, by product, 2015 - 2026 (USD Million)
-
Table South Africa Anthrax Vaccines market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Nigeria Anthrax Vaccines market, by type, 2015 - 2026 (USD Million)
-
Table Nigeria Anthrax Vaccines market, by product, 2015 - 2026 (USD Million)
-
Table Nigeria Anthrax Vaccines market, by application, 2015 - 2026 (USD Million)
-
Table Recent Developments & Impact Analysis, by Key Market Participants
-
Table Recent Developments & Impact Analysis, by Key Market Participants
-
Table Company market position analysis
Table Company Profiles
Table Centro Diagnóstico Veterinario Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table KAKETSUKEN (Chemo-Sero-Therapeutic Research Institute) Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Institute for Biological Products Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Empresa Colombiana de Productos Veterinarios S.A. (PharmAthene) Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Central Veterinary Control and Research Institute Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table CDV Limited Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Colorado Serum Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Jordan Bio-Industries Center (CVCRI) Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Intervac Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Instituto JOVAC S.A. Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Biogénesis-Bago Argentina Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table IVPM (PVT) Ltd. Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Merck Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Laboratorios Laverlam S.A. Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Bayer Sanidad Animal Company Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Zoetis Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Laboratorio Merial S.A. Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Rosenbusch S.A. Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Institute of Animal Health and Veterinary Biologicals Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Indian Immunologicals Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Institutul Pasteur Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Institute of Veterinary Preventive Medicine Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
-
